Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026)
Maze Therapeutics (MAZE) posted Asset Utilization Ratio of 0.05 for Q1 2026, up 111.65% sequentially from 0.42 in Q3 2025, and up 110.4% YoY from 0.02 in Q1 2025.
Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Maze Therapeutics has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.05 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Maze Therapeutics | 1.51 Bn | 1.51 Bn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.04 |
| Mar 31, 2026 | 0.05 |
| Sep 30, 2025 | -0.42 |
| Jun 30, 2025 | -0.47 |
| Mar 31, 2025 | -0.47 |